Equities

Mach7 Technologies Ltd

Mach7 Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.365
  • Today's Change-0.005 / -1.35%
  • Shares traded364.37k
  • 1 Year change-49.31%
  • Beta1.8366
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Mach7 Technologies Ltd's net income fell 660.45% from a loss of1.05m to a larger loss of 7.97m despite relatively flat revenues. A contributing factor has been the increase in the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales).
Gross margin95.19%
Net profit margin-26.56%
Operating margin-31.92%
Return on assets-10.26%
Return on equity-14.32%
Return on investment-12.71%
More ▼

Cash flow in AUDView more

In 2024, Mach7 Technologies Ltd increased its cash reserves by 11.89%, or 2.78m. The company earned 3.45m from its operations for a Cash Flow Margin of 11.50%. In addition the company used 391.31k on investing activities and also paid 32.08k in financing cash flows.
Cash flow per share-0.003
Price/Cash flow per share--
Book value per share0.215
Tangible book value per share0.0998
More ▼

Balance sheet in AUDView more

Mach7 Technologies Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio2.25
Quick ratio--
Total debt/total equity0.0245
Total debt/total capital0.0239
More ▼

Growth rates in AUD

Year on year, growth in earnings per share excluding extraordinary items dropped -655.48%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-655.71
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.